SuperworthAdvanSix market cap ASIX
Share price times shares outstanding: what the whole company sells for, since 2016.
- Today, Oct 23, 2026
- $424.2M
- Highest close in our data
- $1.5B
- Mar 2022
AdvanSix is worth $424.2M at the close on Oct 23, 2026, at $15.71 a share.
That is down 21% over the last year and down 69% over five years.
Its highest close in our data was $1.5B in Mar 2022.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $424.2M | $424.2M | $681.8M | −9% |
| 2025 | $466.9M | $395.4M | $845.5M | −38% |
| 2024 | $752.7M | $570.4M | $868M | −7% |
| 2023 | $807.5M | $663.1M | $1.2B | −23% |
| 2022 | $1B | $894.3M | $1.5B | −21% |
| 2021 | $1.3B | $597.6M | $1.4B | +137% |
| 2020 | $560.3M | $249.6M | $573.2M | +1% |
| 2019 | $552.4M | $551M | $989.8M | −24% |
| 2018 | $731.4M | $688.7M | $1.3B | −43% |
| 2017 | $1.3B | $680.4M | $1.4B | +90% |
| 2016 | $674.9M | $507.2M | $691.4M | n/a |
Against its peers
Companies in Chemicals nearest AdvanSix's size, closest first, today.
| Company | Market cap |
|---|---|
| ASIXAdvanSix | $424.2M |
| FTKFlotek Industries | $865.7M |
| NAGENiagen Bioscience | $192.3M |
| CRONCronos | $1.2B |
| ROGRogers | $2.2B |
| FTLFFitlife Brands | $78.4M |
| NGVTIngevity | $2.4B |
| IOSPInnospec | $2.4B |
| FULFuller H B | $2.7B |
| WDFCWD 40 | $2.9B |
| AVNTAvient | $3.8B |
| Peer median | $2.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on AdvanSix
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.